(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

GALEXI

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

GALEXI

ST13

US500000079315195

Class

42

Filing

79315195

Registration

6881898

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

34

Latest update

03/06/2023

Trademark type

Word

Nice classes

42

Filing date

06/11/2021

Registration date

10/25/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/25/2022

Last transaction

10/25/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

82

Owner location

AU

Examiner

HUSSAIN, TASNEEM

Law office

M90

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Agilex Biolabs Pty Ltd

Representatives

David L. May Nixon Peabody LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Advisory services relating to biochemistry; advisory services relating to pharmacology; advisory services relating to pharmaceutical product testing; advisory services relating to science in the field of bioanalytics; advisory services relating to scientific research in the field of bioanalytics; analysis of materialsbioanalytical services; analytical scientific laboratory services in the field of bioanalytics; biochemistry research services; biochemistry services; biological research; biotechnological research; biotechnology research; biotechnology testing; development of computer systems for the processing of data in the field of bioanalytics; development of chemical production testing methods for medical clinical trials; scientific research in the nature of conducting medical clinical trials for others; consultancy pertaining to pharmacology; laboratory analysis in the field of bioanalytics; laboratory research in the field of bioanalytics; medical research laboratory services; medical laboratory services being scientific research or analysis; laboratory testing services in the field of bioanalytics; pharmaceutical research services; preparation of reports relating to scientific research in the field of bioanalytics; provision of information relating to scientific research in the field of bioanalytics; pharmaceutical product quality testing; research laboratories in the field of bioanalytics; scientific research relating to data processingresearch on development of data processing programs by order of third parties; research relating to medicine; research relating to pharmaceuticals; scientific and technical analysis in the field of bioanalytics; scientific research consultancy in the field of bioanalytics; scientific laboratory services in the field of bioanalytics; scientific research in the field of bioanalytics; scientific testing services in the field of bioanalytics; services for assessing the safety of pharmaceuticals; testing of pharmaceutical products

Publications

History of USPTO decisions and trademark events.

34 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

03/06/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

02/10/2023

FIMP

FINAL DISPOSITION PROCESSED

02/10/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

01/25/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/25/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

10/25/2022

ETOP

EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED

09/18/2022

ETOF

EXTENSION OF TIME TO OPPOSE RECEIVED

06/06/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

05/10/2022

PUBO

PUBLISHED FOR OPPOSITION

05/10/2022

GPNX

NOTIFICATION PROCESSED BY IB

05/09/2022

RFNT

REFUSAL PROCESSED BY IB

04/24/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/20/2022

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

04/20/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/20/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

04/07/2022

XAEC

EXAMINER'S AMENDMENT ENTERED

04/05/2022

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

04/05/2022

GNEA

EXAMINERS AMENDMENT E-MAILED

04/05/2022

CNEA

EXAMINERS AMENDMENT -WRITTEN

04/05/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

04/01/2022

RFRR

REFUSAL PROCESSED BY MPU

03/31/2022

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

03/30/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

03/30/2022

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

03/30/2022

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

03/30/2022

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

03/30/2022

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

03/30/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

03/04/2022

CNRT

NON-FINAL ACTION WRITTEN

03/03/2022

DOCK

ASSIGNED TO EXAMINER

03/03/2022

MAFR

APPLICATION FILING RECEIPT MAILED

07/20/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/15/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

07/08/2021

Continuous trademark protection

Get notified about every new filing that threatens GALEXI or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.